Printer Friendly
The Free Library
14,558,825 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Advanced Medical Optics Launches WhiteStar Signature(TM) Phacoemulsification System with Fusion(TM) Fluidics.


Premium Lens Removal System Combines Proven Performance of Proprietary WHITESTAR([R]) Technology with Safety of Revolutionary Fusion[TM] Fluidics fluidics, branch of engineering and technology concerned with the development of equivalents of various electronic circuits using movements of fluid rather than movements of electric charge.  to Optimize Patient Outcomes

SAN DIEGO -- Advanced Medical Optics Advanced Medical Optics, Inc., (NYSE: EYE) (known as AMO) is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. , Inc. (AMO AMO - America's Multimedia Online ) (NYSE NYSE

See: New York Stock Exchange
:EYE) today announced from the American Society of Cataract and Refractive Surgery (ASCRS ASCRS American Society of Cataract and Refractive Surgery
ASCRS American Society of Colon and Rectal Surgeons
) Meeting in San Diego the launch of the WhiteStar Signature([TM]) phacoemulsification phacoemulsification /phaco·emul·si·fi·ca·tion/ (-e-mul?si-fi-ka´shun) a method of cataract extraction in which the lens is fragmented by ultrasonic vibrations and simultaneously irrigated and aspirated.  system with Fusion([TM]) Fluidics.

The new, advanced technology combines the proven performance of AMO's WhiteStar([R]) technology with the safety of a revolutionary Fusion([TM]) dual pump fluidic flu·id·ic  
adj.
1. Of, relating to, or characteristic of a fluid.

2. Relating to or controlled by fluidics.
 system. A streamlined user interface and easy-to-use accessories enhance efficiency of the operating room environment.

"The WhiteStar Signature([TM]) system combines the efficiency and safety of WhiteStar([R]) phaco technology with improved fluidics that enhance chamber stability," said Dr. David Chang, clinical professor of ophthalmology at the University of California, San Francisco Coordinates:  . "The dual pump represents the next generation in phaco fluidics, and the new user interface is a significant improvement for surgeons and staff."

WhiteStar Signature([TM]) System With Fusion([TM]) Fluidics

One of the most unique features of the WhiteStar Signature([TM]) system is its Fusion([TM]) Fluidics technology. This system provides the ultimate chamber stability and effectively reduces post-occlusion surge by a significant margin. The dual pump responsiveness has the performance of a venturi venturi

a tube with a decrease in the inside diameter that is used to increase the flow velocity of the fluid and thereby cause a pressure drop; used to measure the flow velocity (a venturimeter) or to draw another fluid into the stream.
 pump and the control of a peristaltic peristaltic

pertaining to or emanating from peristalsis.


peristaltic reflex
onward movement of a bolus of ingesta in the intestine is preceded by a reflex dilation of the intestine.
 flow-based pump to provide a stable environment for the surgeon and patient. The user friendly system includes a one step, one hand cassette, intuitive touch screen and intelligent help feature.

About Advanced Medical Optics (AMO)

AMO develops advanced, life-improving vision technologies for people of all ages. Products in the cataract/implant line include intraocular lenses (IOLs), phacoemulsification systems, viscoelastics, and related products used in ocular surgery. AMO owns or has the rights to such product brands as ReZoom([R]), Tecnis([R]), Clariflex([R]), Sensar([R]), and Verisyse([R]) IOLs, Sovereign([R]), Sovereign([R]) Compact and WhiteStar Signature([TM]) phacoemulsification systems with WhiteStar([R]) technology, Healon([R]) viscoelastics, and the Baerveldt([R])glaucoma shunt. Products in the laser vision correction line include wavefront Noun 1. wavefront - (physics) an imaginary surface joining all points in space that are reached at the same instant by a wave propagating through a medium
wave front
 diagnostic devices, femtosecond lasers and associated patient interface devices, and excimer laser vision correction systems and treatment cards. AMO brands in the laser vision correction business include Star S4 IR([R]), WaveScan Wavefront([R]), CustomVue([R]), IntraLase([R]) FS, IntraLase Method([TM]) and IntraLasik([R]). Products in the contact lens care line include disinfecting solutions, enzymatic cleaners and lens rewetting drops. Among the eye care product brands the company possesses are COMPLETE Moisture PLUS([R]), COMPLETE([R]) Blink-N-Clean([R]), Consept([R])F, Consept([R]) 1 Step, Oxysept([R]) 1 Step, UltraCare([R]), Ultrazyme([R]), Total Care([TM]) and blink[TM] branded products. AMO is based in Santa Ana, California Santa Ana is the most populous city in Orange County, California and is the county seat. It lies approximately 10 miles inland from the Pacific Ocean, on the largely seasonal Santa Ana River. , and employs approximately 4,200 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries. For more information, visit the company's Website at www.amo-inc.com.

Forward-Looking Statements

This press release contains forward-looking statements about AMO, including Dr. Chang's statements and those relating to the launch and features of the product. All forward-looking statements in this press release are based on estimates and assumptions and represent AMO's judgment only as of the date of this press release. Actual results may differ from current expectations based on a number of factors including but not limited to market developments, expanded clinical experience, unexpected delays in manufacturing, and unexpected regulatory or quality issues. Therefore, the reader is cautioned not to rely on these forward-looking statements. AMO disclaims any intent or obligation to update these forward-looking statements. Additional information concerning these and other risk factors may be found in previous press releases issued by AMO and AMO's public periodic filings with the Securities and Exchange Commission, including the discussion under the heading "Risk Factors" in AMO's 2006 Form 10-K filed in March 2007. Copies of press releases and additional information about AMO are available at www.amo-inc.com.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 27, 2007
Words:649
Previous Article:Coach, Inc. to Present at the Lehman Brothers Retail Seminar.
Next Article:Zacks Broker Upgrades: Clear Channel, Caterpillar, Goldman Sachs and Lehman Brothers.



Related Articles
GroOs out? (You Can Do It).(Brief Article)
Advanced Medical Optics Files Complaint Against Alcon, Inc. for Infringement of U.S. Patents.
Advanced Medical Optics to Present at the Banc of America Securities New Products, New Paradigms in Health Care Conference.
Advanced Medical Optics to Present at Two Investor Conferences in February 2007.
Advanced Medical Optics Announces Release Date for Fourth Quarter and Full Year 2006 Operating Results.(Financial report)
Advanced Medical Optics Announces Release Date for First Quarter 2007 Operating Results.(Financial report)
Advanced Medical Optics to Present at the Bank of America 2007 Healthcare Conference on May 30.
Advanced Medical Optics Announces the Addition of Robert J. Palmisano to Its Board of Directors.
Advanced Medical Optics to Conduct Conference Call With Investment Community.
Advanced Medical Optics to Conduct Conference Call with Investment Community.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles